Efficacy and safety of radiofrequency catheter ablation in younger children with ventricular arrhythmias

射频导管消融术治疗低龄室性心律失常患儿的疗效和安全性

阅读:1

Abstract

BACKGROUND AND AIMS: To compare the clinical characteristics of ventricular arrhythmias (VAs) in younger vs. older children, and to explore the safety and efficacy of radiofrequency catheter ablation (RFCA) in the treatment of VAs in young children. METHODS: General data, surgical data, and prognosis of all children with VAs who underwent RFCA at our hospital between 1 January 2005 and 31 December 2022 were retrospectively analysed. Patients were divided into two groups according to age: younger (<4 years); and older (≥4 years). RESULTS: Data from 762 children with VAs were analysed, including 96 younger children (3.47 ± 0.75 years, 16.74 ± 3.98 kg) and 666 older children (9.44 ± 2.86 years, 38.85 ± 15.11 kg). Compared with the older group, there were more premature ventricular beats with ventricular tachycardia, earlier surgery, and more ablations under x-ray fluoroscopy in the younger group. The right ventricular outflow tract was the most common arrhythmia focus in both groups, followed by the tricuspid annulus in the younger group and the left ventricular septum in the older group. The acute success rates for younger and older children were 99.0% and 98.6%, respectively. The recurrence and complication rates in the two groups were similar, and there was no significant difference in radiation dose. CONCLUSIONS: The safety and efficacy of RFCA in the treatment of younger children with VAs were similar to those of older children. RFCA appears to be a viable therapeutic option for young children with drug-resistant VAs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。